Anthropic Operates AI Biology Lab While Warning About Bioweapon Risks
10 Sources
[1]
Anthropic is operating a lab that conducts biology experiments
Anthropic has confirmed that it has a wet biology lab where it can use its AI models to run physical experiments. AI leaders have been promising that AI is the key to curing human disease. Dario Amodei opined just last week: "I believe that AI could cure most major diseases in the next 5-10
[2]
EXCLUSIVE: Anthropic quietly sets up biology lab as it ramps AI drug program
SAN FRANCISCO, Sept 18 (Reuters) - Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. At a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical
[3]
Anthropic has set up a bio research lab for physical experiments - Engadget
Anthropic has established a biology research lab in the San Francisco Bay Area to conduct physical experiments, according to Reuters. Eric Kauderer-Abrams, the company's Head of Life Sciences, has confirmed the lab's existence to the news organization. "We believe that to do biology, the final test
[4]
Anthropic quietly sets up biology lab as it ramps AI drug program: Reuters
Follow your favorite stocksCREATE FREE ACCOUNT Cfoto | Future Publishing | Getty Images Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. At a time when fears of AI are gripping the public, the
[5]
While Issuing Warnings About AI-Made Bioweapons, Anthropic Quietly Set Up an AI-Run, Robot-Operated Biology Lab Here in the US
Just one week after Anthropic released a report claiming to have shut down potential bioweapons development conducted by unnamed users of its Claude AI, details have now emerged that the AI firm has also been quietly running a robotically automated and AI-operated biology lab itself. Reuters
[6]
Anthropic builds wet lab for AI-driven drug discovery
Anthropic has set up a wet lab in the San Francisco Bay Area to conduct physical biology experiments, as the company moves beyond computer-based research in its effort to develop treatments for rare diseases. Eric Kauderer-Abrams, Anthropic's head of life sciences, confirmed the lab's existence in
[7]
Anthropic quietly sets up biology lab as it ramps AI drug program
At a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisco Bay Area, two people familiar with the matter said. Anthropic has said it wants to unlock treatments for rare diseases, and its biology work has gone beyond
[8]
Anthropic's Drug Discovery Bet Gets Real: AI Startup Sets Up Physical Biology Lab
Anthropic is taking its push into life sciences out of the cloud and into the lab. The artificial intelligence startup has established a physical biology facility in the San Francisco Bay Area, marking a deeper move into hands-on experimentation as it expands its work in drug research. Two people
[9]
Anthropic quietly sets up biology lab as it ramps AI drug program - The Korea Times
The company has said it is not running clinical trials for now and is focusing on needs that industry would not address. SAN FRANCISCO -- Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. At a
[10]
Anthropic quietly sets up biology lab as it ramps AI drug program
SAN FRANCISCO, Sept 18 (Reuters) - Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. At a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical
Share
Copy Link
Anthropic confirmed it runs a wet lab in the San Francisco Bay Area where its Claude AI can direct robotic units to conduct physical biology experiments. The revelation comes just weeks after the company warned about AI-enabled bioterrorism risks and called for industry self-regulation, creating tensions between its ambitious life sciences goals and safety concerns.
Anthropic Confirms Physical Biology Lab Operations
Anthropic has confirmed it operates a wet lab in the San Francisco Bay Area where it conducts physical biology experiments using its AI models
1
2
. Eric Kauderer-Abrams, Anthropic's head of life sciences, told Reuters that "to do biology, the final test is still, and will be for a while, in real lab work"2
. The facility represents a significant step in the company's AI drug program and broader life sciences ambitions, moving beyond computer-based evaluations to real-world testing.
Source: Benzinga
Automation and Robotics Integration
The startup is exploring how its Claude models can direct robotic units to carry out science experiments with limited human intervention, according to sources familiar with the matter
2
5
. Kauderer-Abrams described this as being "in the very early innings of using AI to automate the execution of lab work," calling it "an area that has the potential to bring about meaningful acceleration in so many different processes"2
. The company maintains that human oversight remains essential for safety in these AI-driven scientific research operations3
.Strategic Approach to Drug Development
Anthropic's approach combines in-house research with external partnerships, typical of most biotech companies
2
. A company spokesperson clarified that the biology lab is not focused specifically on drug discovery, though the company has stated intentions to tackle rare diseases that pharmaceutical companies often neglect1
4
. At a San Francisco event in June, Kauderer-Abrams announced Anthropic would conduct preclinical work in areas traditional companies find financially unattractive4
. The company launched Claude Science software and acquired Coefficient Bio for approximately $400 million in stock to build tools for AI-driven drug development4
.Personal Mission and Industry Partnerships
For Dario Amodei, Anthropic's CEO, the effort carries personal significance. A disease killed his father only a few years before a cure became available, he revealed in a recent essay
2
. Amodei has stated his belief that "AI could cure most major diseases in the next 5-10 years"1
. The company has secured partnerships with major pharmaceutical players, including adding Novartis CEO Vas Narasimhan to its board and announcing a joint drug discovery deal with Novo Nordisk1
4
. Anthropic also launched a Life Sciences Verification Program to give vetted researchers access to its most powerful models1
.
Source: Gizmodo
Related Stories
Contradictions Between Warnings and Actions
The timing of the wet lab revelation has sparked controversy within the tech industry. Just weeks before confirming the facility's existence, Anthropic researcher Jacob Coxon resigned, warning that "the people building AI earnestly believe that it could kill us all by the end of the decade"
1
. Anthropic's own alignment lead assessed the odds at greater than 10% that AI could cause human extinction within the next decade1
. Dario Amodei published a post calling for industry self-regulation and has repeatedly identified bioterrorism as one of AI's biggest risks1
5
. Anthropic recently reported finding examples where its systems could have been used toward biological weapons development, though this claim met some skepticism4
. MIT synthetic biologist Kevin Esvelt revealed that an AI chatbot recently suggested "a novel form of bioweapon" he hadn't realized was possible, highlighting AI's dual-use potential in biotechnology5
.
Source: Korea Times
Expansion Plans and Industry Impact
Anthropic is actively hiring to expand its biology lab operations, seeking a leader to ramp up procurement and other operations according to LinkedIn job posts
4
. Another role sought an expert on "protein and nucleic acid characterization," while a third listing stated: "Our goal is to speed up progress in the life sciences by an order of magnitude"4
. Kauderer-Abrams emphasized the company's goal "to operate at the largest possible scale"4
. The company is preparing for a potentially $2 trillion IPO to raise more funds for AI development4
. As Kauderer-Abrams stated, "The mission of the company is to develop powerful AI in such a way that benefits the world. By far, we see the biggest opportunity for that in the life sciences"2
. The success of any drug program remains uncertain, as most drugs fail to pass trials for clinical safety and efficacy2
.References
Summarized by
Navi
Related Stories
Anthropic launches Claude Science workbench and plans to develop drugs for rare diseases
30 Jun 2026•Technology
Anthropic Launches Claude for Life Sciences, Aiming to Revolutionize Scientific Research
20 Oct 2025•Science and Research
Anthropic draws $800 billion offers as OpenAI faces investor scrutiny over strategic shifts
14 Apr 2026•Business and Economy
Recent Highlights
1
OpenAI Claims AI Breakthrough on Navier-Stokes Problem, Sparking Math Community Crisis
Science and Research
2
Anthropic's Claude Now Leads 26% of AI Development Work, Company Reveals New Transparency Metrics
Technology
3
OpenAI Reveals AI Models Hiding Mistakes and Taking Unauthorized Actions in 6 New Misalignment Cases
Technology
Recent Highlights
Today's Top Stories
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.
